Proteomics in diagnostic neuropathology

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 9, 2006, Pages 837-845

  Johnson, Mahlon D ^a   Floyd, John L ^b   Caprioli, Richard M ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Laser capture; Mass spectrometry; Matrix assisted laser desorption ionization mass spectrometry (MALDI MS); Microdissection; Protein signatures; Proteomics

Indexed keywords

PROTEOME;

CENTRAL NERVOUS SYSTEM DISEASE; CHEMOSENSITIVITY; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC ANALYSIS; GENOME; GLIOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR GENETICS; MOLECULAR WEIGHT; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PATHOGENESIS; PERIPHERAL NEUROPATHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MICRODISSECTION; NERVOUS SYSTEM DISEASES; PATHOLOGY, CLINICAL; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33748552348     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000235116.67558.24     Document Type: Review

References (57)

1. Hirano T, Kato H. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer. Ann Thorac Cardiovasc Surg 2006;12:4-9
2. Kalia A, Gupta RP. Proteomics: A paradigm shift. Crit Rev Biothechnol 2005;25:173-98
3. Lahm HW, Langen H. Mass spectrometry: A tool for the identification of proteins separated by gels. Electrophoresis 2000;21:2105-14
4. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000;405:837-46
5. McDonald WH, Yates JR. Proteomic tools for cell biology. Traffic 2000;1:747-54
6. Aebersold R, Goodlett DR. Mass spectrometry in proteomics. Chem Rev 2001;101:269-95
7. Brown RS, Lennon JJ. Mass resolution improvement by incorporation of pulsed ion extraction in a matrix-assisted laser-desorption ionization linear time-of-flight mass-spectrometer. Anal Chem 1995;67:1998-2003
8. Vestal ML, Juhasz P, Martin SA. Delayed extraction matrix-assisted laser-desorption time-of-flight mass-spectrometry. Rapid Commun Mass Spectrom 1995;9:1044-50
9. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: New technology for the analysis of protein expression in mammalian tissues. Nat Med 2001;7:493-96
10. Todd PJ, Schhaaff TG, Chaurand P, Caprioli RM. Organic ion imaging of biological tissue with SIMS and MALDI. J Mass Spectrom 2001;36:355-69
11. Chaurand P, Caprioli RM. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002;23:3125-35
12. Chaurand P, Schwartz SA, Caprioli RM. Imaging mass spectrometry: A new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 2002;6:676-81
13. Troendle FJ, Reddick CD, Yost RA. Detection of pharmaceutical compounds in tissue by matrix-assisted laser desorption/ionization and laser desorption/chemical ionization tandem mass spectrometry with a quadrupole ion trap. J Am Soc Mass Spectrom 1999;10:1315-21
14. Reyzer ML, Hsieh Y, Ng K, Korfmacher WA, Caprioli RM. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 2003;38:1081-92
15. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001
16. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: Molecular analysis of tissue. Science 1997;278:1481-83
17. Bichsel VE, Petricoin EF, Liotta LA. The state of the art microdissection and its downstream applications. J Mol Med 2000;78:B20
18. Chaurand P, Schwartz SA, Caprioli RM. Profiling and imaging proteins in tissue sections by mass spectrometry. Anal Chem 2004;76:86A-93A
19. Palmer-Toy DE, Sarracino DA, Sgroi D, LeVangie R, Leopold PE. Direct acquisition of matrix-assisted laser desorption/ionization time-of-flight mass spectra from laser capture microdissected tissues. Clin Chem 2000;46:1513-16
20. Xu BJ, Caprioli RM, Sanders ME, Jensen RA. Direct analysis of laser capture microdissected cells by MALDI mass spectrometry. J Am Soc Mass Spectrom 2002;13:1292-97
21. Bhattacharya SH, Gal AA, Murray KK. Laser capture microdissection MALDI for direct analysis of archival tissue. J Proteome Res 2003;2:95-98
22. Stoeckli M, Farmer TB, Caprioli RM. Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument. J Am Soc Mass Spectrom 1999; 10:67-71
23. Schwartz SA, Reyzer ML, Caprioli RM. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: Practical aspects of sample preparation. J Mass Spectrom 2003;38:699-708
24. Kruse R, Sweedler JV. Spatial profiling invertebrate ganglia using MALDI MS. J Am Soc Mass Spectrom 2003;14:752-59
25. Fournier I, Day R, Salzet M. Direct analysis of neuropeptides by in situ MALDI-TOF mass spectrometry in the rat brain. Neuroendocrinol Lett 2003;24:9-14
26. Bahr U, StahlZeng J, Gleitsmann E, Karas M. Delayed extraction time-of-flight MALDI mass spectrometry of proteins above 25,000 Da. J Mass Spectrom 1997;32:1111-16
27. Brunelle A, Chaurand P, Della Negra S, LeBeyec Y, Parilis E. Secondary electron emission yields from a CsI surface under impacts of large molecules at low velocities (5 x 10[3]- 7 x 10[4] ms[-1]). Rapid Commun Mass Spectrom 1997;11:353-62
28. Westmacott G, Frank M, Labov SE, Benner WH. Using a super-conducting tunnel junction detector to measure the secondary electron emission efficiency for a microchannel plate detector bombarded by large molecular ions. Rapid Commun Mass Spectrom 2000;14:1854-61
29. Chaurand P, Schwartz SA, Billheimer D, Xu BJ, Crecelius A, Caprioli RM. Integrating histology and imaging mass spectrometry. Anal Chem 2004;76:1145-55
30. Garden RW, Sweedler JV. Heterogeneity within MALDI samples as revealed by mass spectrometric imaging. Anal Chem 2000;72:30-36
31. Spengler B, Hubert M. Scanning microprobe matrix-assisted laser desorption ionization (SMALDI) mass spectrometry: Instrumentation for sub-micrometer resolved LDI and MALDI surface analysis. J Am Soc Mass Spectrom 2002;13:735-48
32. Chaurand P, Fouchecourt S, DaGue BB, Xu BJ, Reyzer ML, Orgebin-Crist MC, Caprioli RM. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry. Proteomics 2003;3:2221-39
33. Craven RA, Banks RE. Laser capture microdissection and proteomics: Possibilities and limitation. Proteomics 2001;1:1200-04
34. Aerni HR, Cornett DS, Chaurand P, et al. Automated sample preparation for MALDI imaging MS. Proceedings of the 52nd ASMS Conference on Mass Spectrometry and Allied Topics, Nashville TN, 2004
35. Chaurand P, DaGue BB, Pearsall RS, Threadgill DW, Caprioli RM. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2001;1:1320-26
36. Iwadate Y, Sakaida T, Hiwasa T, et al. Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res 2004;64:2496-2501
37. Schwartz SA, Weil RJ, Johnson MD, et al. Protein profiling in brain tumors using mass spectrometry. Clin Cancer Res 2004;10:981-87
38. Schwartz SA, Weil RJ, Thompson RC, et al. Proteomic-based prognosis of brain tumor patients using direct tissue-matrix assisted laser desorption mass spectroscopy. Cancer Res 2005;65:7674-81
39. Caprioli RM. Deciphering protein molecular signatures in cancer tissue to aid in diagnosis, prognosis and therapy. Cancer Res 2005;65:10642-45
40. Fuller CE, Perry A. Molecular diagnostics in central nervous system tumors. Adv Anat Pathol 2005;12:180-94
41. Johnson M, Toms S. Meningioma signal transduction pathways as targets for novel chemotherapies. J Neuropathol Exp Neurol 2005;64:1029-36
42. Sanai N, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005;353:811-22
43. Vogel TW, Zhaung Z, Li J, et al. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme. Clin Cancer Res 2005;11:3624-32
44. Zheng PP, Luider TM, Pieters R, et al. Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors. J Neuropathol Exp Neurol 2003;62:855-62
45. Urbani A, Poland J, Bernardini S, et al. A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines. Proteomics 2005;5:796-804
46. Zhang J, Goodlet DR, Peskind ER, et al. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging 2005;26:207-27
47. Butterfield DA. Proteomics: A new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 2004;1000:1-7
48. Kawaja MD. A proteomic approach to assess intraneuronal inclusions associated with neurodegenerative disorders. Curr Opin Mol Ther 2005;7:756-58
49. Woltjer RL, Cimino PJ, Boutte AM, et al. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. FASEB J 2005;19:1923-25
50. Wang Q, Woltjer RL, Cimino PJ, et al. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GADPH as a detergent insoluble paired helical filament tau binding protein. FASEB J 2005;19:869-71
51. Ranganathan S, Williams E, Ganchev P, et al. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 2005;95:1461-71
52. Johnston-Wilson NL, Sims CD, Hofmann JP, et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology ConsortiumMol Psychiatry 2000;5:142-49
53. Hammack BN, Fung KY, Hunsucker SW, et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 2004;10:245-60
54. Dumont D, Noben JP, Raus J, et al. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004;4:2117-24
55. Missall TA, Pusateri ME, Lodge JK. Thiol peroxidase is critical for virulence and resistance to nitric oxide and peroxide in the fungal pathogen, cryptococcus neoformans. Mol Microbiol 2004;51:1447-58
56. Bernadini G, Renzone G, Camanducci M, et al. Proteome analysis of Neisseria meningitides serogroup A. Proteomics 2004;4:2893-926
57. Gary RF, Dash S. Proteomics computational analyses suggests that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. Virology 2004;307:255-65